Company Profile: Danaher Corporation (DHR)
DHR insider trades (13 months) →$230.11 +0.94% vs. previous close · Market cap $161.76B
Today's multi-factor rank: 321 of 461 · see the ranking
Market and Valuation
Price & Market
52-Week Range
Volume
Valuation Multiples
Diluted EPS for the last 12 months: the four quarters ended Sep 25, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.
Dividends
Valuation Context
P/E vs sector (indicative)
Loading historical OHLCV database...
Financial Statements TTM (Trailing 12 Months)
Income Statement
Margins
Per Share
Diluted EPS for the last 12 months: the four quarters ended Sep 25, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.
Balance Sheet & Liquidity
Cash Flows
Profitability
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
Diluted EPS for the last 12 months: the four quarters ended Sep 25, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.
Growth and Margins
Per Share
Cash Flows (TTM)
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
| Quarter | Period | Actual EPS | Estimated EPS | Difference | Surprise % | Currency |
|---|
Ownership Structure
Ownership Distribution
Shares & Short Interest
Governance Score (1=Best, 10=Worst)
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
| Organization | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
| Fund | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Recent Insider Trades
| Executive / Insider | Title | Date | Action | Shares |
|---|
Options Chain
CALLS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
PUTS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
Danaher Corporation (DHR) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
| Type | Date | Official link |
|---|---|---|
| 8-K | 2026-10-21 | View filing ↗ |
| 8-K | 2026-10-13 | View filing ↗ |
| 25-NSE | 2026-09-30 | View filing ↗ |
| 8-K | 2026-08-03 | View filing ↗ |
| 8-K | 2026-07-21 | View filing ↗ |
| 11-K | 2026-06-16 | View filing ↗ |
| S-8 | 2026-06-09 | View filing ↗ |
| 8-K | 2026-06-03 | View filing ↗ |
| SD | 2026-05-12 | View filing ↗ |
| 8-K | 2026-05-07 | View filing ↗ |
Company and Executive Profile
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
General Information
Key Executives
| Name | Title | Age | Total pay |
|---|---|---|---|
| Mr. Steven M. Rales | Co-Founder & Chairman | 74 | - |
| Ms. Julie Sawyer Montgomery | President, CEO & Director | 53 | 2.58M |
| Mr. Mitchell P. Rales | Co-Founder & Director | 68 | - |
| Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Senior VP & Chief Science Officer | 63 | 2.52M |
| Mr. Matthew R. McGrew | Executive Vice President | 53 | 3.17M |
| Mr. Rainer M. Blair | Senior Advisor | 61 | 6.12M |
| Mr. Christopher Paul Riley | Executive VP of Biotechnology Group & CEO of Cytiva | 51 | 2.54M |
| Mr. Matthew E. Gugino C.F.A., CPA | Executive VP & CFO | 42 | - |
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.